Interesting seeing Victoria is now "home" of the mRNA technology in Australia and could become a world leader in producing mRNA vaccines. This is great news for exopharm should exosomes become the way of delivering mRNA in the future (which is what we believe given the investment in this stock). One for the bottom drawer but one I am holding with excitement albeit a horrible share price decline.
imo dyor gltah
EX1 Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held
